Skip to content
healthcare.dev
Get a free key

Shiseido Future Solution LX Total Protective

NDC 58411-327, AVOBENZONE, OCTINOXATE, OCTOCRYLENE, and OXYBENZONE, emulsion, from SHISEIDO AMERICAS CORPORATION.

Product NDC
58411-327
Status
Listed
Labeler
SHISEIDO AMERICAS CORPORATION
Dosage form
EMULSION
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M020
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58411-327 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AVOBENZONE1136 mg/75mL
  • OCTINOXATE5606 mg/75mL
  • OCTOCRYLENE1515 mg/75mL
  • OXYBENZONE758 mg/75mL
Package NDCNDC-11Package
58411-327-10584110327101 BOTTLE, PLASTIC in 1 CARTON (58411-327-10) / 75 mL in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 58411-327 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58411-327 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58411-327. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.